Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Medilabo is a prominent Algerian pharmaceutical company specializing in the development, manufacturing, and distribution of generic medicines. Established in 2005, the company operates a state-of-the-art manufacturing facility in Zeralda, Algiers, which adheres to international quality standards for pharmaceutical production. Medilabo's extensive portfolio covers a wide range of therapeutic areas, including cardiology, neurology, gastroenterology, and metabolic diseases, providing essential and affordable treatments to the North African market. The company is a key player in the regional pharmaceutical industry, focused on enhancing local production capabilities and improving patient access to high-quality healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medilabo RFP.